Literature DB >> 6140133

Effects of model traumatic injury on hepatic drug metabolism in the rat. I. In vivo antipyrine metabolism.

L K Griffeth, G M Rosen, C Tschanz, E J Rauckman.   

Abstract

Hind-limb ischemia secondary to infrarenal aortic ligation in the rat was evaluated as a traumatic injury model for the study of the effects of trauma on the two major hepatic microsomal drug-oxidizing enzyme systems. Ischemic injury resulted in a significant decrease in hepatic cytochrome P-450 content and FAD-containing monooxygenase activity. Bilateral lower leg fracture was used as a dissimilar traumatic injury model in order to confirm these results and produced similar effects on these enzyme systems. Both forms of injury appeared to be of only moderate severity, and neither injury caused significant histopathological changes in the liver. Moreover, both injuries caused only mild hepatic damage as indicated by relatively modest elevations in glutamic-pyruvic transaminase levels. The observed reductions of cytochrome P-450 content with both forms of model injury were paralleled by decreases in the in vivo metabolism of antipyrine. Thus, it appears that trauma may have a significant, and possibly selective, effect on hepatic drug metabolism, suggesting that careful monitoring and/or dosage adjustment may be in order in some cases of post-traumatic drug therapy. Moreover, the ischemic injury produced by infrarenal aortic ligation in the rat appears to be a suitable small mammal injury model for the further study of the effects of trauma on the various hepatic drug-metabolizing enzyme systems.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6140133

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  7 in total

1.  Extrahepatic ischemia-reperfusion injury reduces hepatic oxidative drug metabolism as determined by serial antipyrine clearance.

Authors:  B J Gurley; G W Barone; K Yamashita; S Polston; M Estes; A Harden
Journal:  Pharm Res       Date:  1997-01       Impact factor: 4.200

2.  The effects of acute-phase inducers and dimethyl sulphoxide on delta-aminolaevulinate synthase activity in human HepG2 hepatoma cells.

Authors:  F Iwasa; S Sassa; A Kappas
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

Review 3.  Pharmacokinetics and pharmacodynamics in critically ill patients.

Authors:  H J Mann; D W Fuhs; F B Cerra
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

4.  Oxicams: relative safety and anti-injury effects in rats.

Authors:  M W Whitehouse
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

5.  Increases in metabolism of valproate and excretion of 6beta-hydroxycortisol in patients with traumatic brain injury.

Authors:  G D Anderson; A B Awan; C A Adams; N R Temkin; H R Winn
Journal:  Br J Clin Pharmacol       Date:  1998-02       Impact factor: 4.335

6.  Role of interleukin-1 in the depression of liver drug metabolism by endotoxin.

Authors:  P Ghezzi; B Saccardo; P Villa; V Rossi; M Bianchi; C A Dinarello
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

7.  Changes in serum levels of quinolones in rats under the influence of experimental trauma.

Authors:  A Trichilis; C Tesserommatis; D Varonos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2000 Apr-Jun       Impact factor: 2.569

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.